Title:
USE OF RED NOCARDIA CELL WALL SKELETON FOR PREPARING PHARMACEUTICAL FOR TREATING LICHEN PLANUS
Document Type and Number:
WIPO Patent Application WO/2020/143393
Kind Code:
A1
Abstract:
The present application relates to a use of red Nocardia cell wall skeleton for preparing a pharmaceutical for treating lichen planus. Specifically disclosed is: a red Nocardia cell wall skeleton effectively reduces the eroded area of lichen planus, reducing the pain level, and after use, exhibits good therapeutic efficacy. In the first report of the present application, the cell wall skeleton of Nocardia red is used to treat erosive oral lichen planus, and its efficacy and safety has been preliminarily observed.
Inventors:
GAI BO (CN)
DOU CHUNYAN (CN)
ZHANG YI (CN)
ZHANG GUOYING (CN)
DOU CHUNYAN (CN)
ZHANG YI (CN)
ZHANG GUOYING (CN)
Application Number:
PCT/CN2019/125185
Publication Date:
July 16, 2020
Filing Date:
December 13, 2019
Export Citation:
Assignee:
LIAONING GREATEST BIO PHARMACEUTICAL CO LTD (CN)
International Classes:
A61K35/74; A61K9/00; A61P1/02
Domestic Patent References:
| WO2005023277A1 | 2005-03-17 |
Foreign References:
| CN1879661A | 2006-12-20 | |||
| CN102895264A | 2013-01-30 |
Other References:
YAO, YANAN; YAO, HUA; YAN, DUODUO; LYU, KEJIA; GONG, LIJUN; WANG, GUOHUA: "Meta-analysis on Correlation between Oral Lichen Planus and Candida Albicans Infection", JOURNAL OF JILIN UNIVERSITY (MEDICINE EDITION), vol. 43, no. 5, 30 September 2017 (2017-09-30), pages 967 - 974, XP009522023, DOI: 20200219181936Y
Attorney, Agent or Firm:
GE CHENG & CO., LTD. (CN)
Download PDF: